Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sang

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science Advances|May 27, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Cell Reports|June 23, 2022
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Iscience|September 15, 2021
A resource of high-quality and versatile nanobodies for drug deliveryZhuolun Shen, Yufei Xiang, Sandra Vergara, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopesDapeng Sun, Zhe Sang, Yong Joon Kim, et al.
Nature Communications|August 4, 2021
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopesDapeng Sun, Zhe Sang, Yong Joon Kim, et al.
Nature Communications|May 20, 2026
Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxinsYong Joon Jeffrey Kim, Nicholas R Walton, Wei Huang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Multivalent Nanobodies for Potent and Broad Neutralization of <i>Staphylococcus aureus</i> ToxinsYong Joon Jeffrey Kim, Nicholas R Walton, Wei Huang, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Multispecific nanobody degraders co-deplete membrane receptors and enable targeted delivery of diverse payloadsMd Kabir, Yong Joon Jeffrey Kim, Zhijie Deng, et al.
Cell|October 24, 2024
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapyYufei Xiang, Jialu Xu, Briana L McGovern, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science Advances|May 27, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Cell Reports|June 23, 2022
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Iscience|September 15, 2021
A resource of high-quality and versatile nanobodies for drug deliveryZhuolun Shen, Yufei Xiang, Sandra Vergara, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopesDapeng Sun, Zhe Sang, Yong Joon Kim, et al.
Nature Communications|August 4, 2021
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopesDapeng Sun, Zhe Sang, Yong Joon Kim, et al.
Nature Communications|May 20, 2026
Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxinsYong Joon Jeffrey Kim, Nicholas R Walton, Wei Huang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Multivalent Nanobodies for Potent and Broad Neutralization of <i>Staphylococcus aureus</i> ToxinsYong Joon Jeffrey Kim, Nicholas R Walton, Wei Huang, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Multispecific nanobody degraders co-deplete membrane receptors and enable targeted delivery of diverse payloadsMd Kabir, Yong Joon Jeffrey Kim, Zhijie Deng, et al.
Cell|October 24, 2024
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapyYufei Xiang, Jialu Xu, Briana L McGovern, et al.
Pageof 2